Zejula 100 mg
In stock
Description
Zejula 100 mg (niraparib) is an oral PARP inhibitor prescription medicine used as maintenance therapy for adults with recurrent or advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer. It works by blocking enzymes (PARP-1/2) that repair DNA in cancer cells, causing them to die.
Specifications
| Strength | 100 mg |
|---|---|
| Main Ingredients | Niraparib |
| Uses | Blood Cancer |
| Pack Size | 4x2x7 Tablets |
| Packing | Box |
